Biomarker Testing for People With Advanced Lung Cancer in England

INTRODUCTION: Optimal management of people with advanced NSCLC depends on accurate identification of predictive markers. Yet, real-world data in this setting are limited. We describe the impact, timeliness, and outcomes of molecular testing for patients with advanced NSCLC and good performance statu...

Descripción completa

Detalles Bibliográficos
Autores principales: Adizie, Jana B., Tweedie, Judith, Khakwani, Aamir, Peach, Emily, Hubbard, Richard, Wood, Natasha, Gosney, John R., Harden, Susan V., Beckett, Paul, Popat, Sanjay, Navani, Neal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474239/
https://www.ncbi.nlm.nih.gov/pubmed/34590024
http://dx.doi.org/10.1016/j.jtocrr.2021.100176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474239/
https://www.ncbi.nlm.nih.gov/pubmed/34590024
http://dx.doi.org/10.1016/j.jtocrr.2021.100176

Ejemplares similares